Genomics

Dataset Information

0

Common differentiating agents facilitate transcriptional reprogramming by bromodomain inhibition


ABSTRACT: Dimethyl sulfoxide (DMSO) and hexamethylene bisacetamide (HMBA) are biologically active molecules that have shown clinical efficacy in cancer and inflammation, though their therapeutic application has been limited, partly because their mechanism of action is unknown. We demonstrate that DMSO and HMBA facilitate rapid transcriptional reprogramming via competitive inhibition of bromodomain-containing proteins. These results identify novel therapeutic avenues and provide context to over 50 years of biomedical research with these agents.

ORGANISM(S): Homo sapiens

PROVIDER: GSE54548 | GEO | 2016/12/25

SECONDARY ACCESSION(S): PRJNA237012

REPOSITORIES: GEO

Similar Datasets

2013-04-23 | GSE43849 | GEO
2013-04-23 | GSE40754 | GEO
| E-GEOD-43849 | biostudies-arrayexpress
| E-GEOD-40754 | biostudies-arrayexpress
2020-04-01 | GSE129921 | GEO
2020-06-06 | GSE91042 | GEO
| E-GEOD-35797 | biostudies-arrayexpress
2015-04-06 | GSE59871 | GEO
2014-07-20 | GSE59496 | GEO
2016-01-29 | GSE77327 | GEO